Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.annemergmed.2023.09.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Nurses' Views on Barriers to Oral Care in Non-Mechanically Ventilated Patients in the Intensive Care Unit: A Qualitative Study.
Nurs Crit Care
September 2025
School of Nursing and Midwifery, Monash University, Frankston, Victoria, Australia.
Background: Optimal oral care is essential in preventing non-ventilator hospital-associated pneumonia and enhancing patient comfort. However, nurses' clinical oral care practices for patients not on mechanical ventilation in the intensive care unit are both underreported and understudied.
Aim: To explore intensive care nurses' clinical oral care practices for patients not on mechanical ventilation in intensive care units.
The Limits of Digital Health for Primary Care Patients and Clinicians: Communication, Information Exchange, and Portal Use.
Health Commun
September 2025
Department of Library and Information Science, Rutgers University.
Patient portals have the potential to both improve and harm patient-clinician partnerships by reshaping how health information is exchanged and how patients and providers communicate. Patients ( = 20) and primary care clinicians ( = 11) purposively sampled from clinics serving diverse New Jersey communities were interviewed. Patients distinguished two portal functions - linear information exchange and bidirectional communication - but did so in different ways.
View Article and Find Full Text PDFPreclinical Ischemic Stroke Multicenter (PRISM) Trials Collective Statement: Opportunities, Challenges, and Recommendations for a New Era.
Stroke
September 2025
Department of Neurology, Yale School of Medicine, New Haven, CT (L.H.S.).
Preclinical stroke research faces a critical translational gap, with animal studies failing to reliably predict clinical efficacy. To address this, the field is moving toward rigorous, multicenter preclinical randomized controlled trials (mpRCTs) that mimic phase 3 clinical trials in several key components. This collective statement, derived from experts involved in mpRCTs, outlines considerations for designing and executing such trials.
View Article and Find Full Text PDFSex- and gender-responsive management of anxiety disorders: future pathways for research, education, policy and practice.
Med J Aust
September 2025
University of New South Wales, Sydney, NSW.
Anxiety disorders are the most prevalent mental illness in Australia and are more common in women relative to men, as well as transgender and gender diverse people relative to cisgender people. Sex and gender differences in anxiety prevalence are likely driven by a combination of factors including differential exposure to different types of stressors and trauma, gendered enculturation of different coping responses and perceived stigma of mental illness, differences in medical comorbidities, and differences in symptom presentations. The established impact of gonadal hormone changes on anxiety risk and symptom presentation across the female lifespan underscore the need for sex- and gender-responsive management of anxiety disorders.
View Article and Find Full Text PDFPost-trial access practices in conducted clinical trials for Malaria, Tuberculosis, and Neglected Tropical Diseases (NTDs) across Sub-Saharan African countries: A quantitative study.
Open Res Eur
September 2025
Clinical trial unit, Armauer Hansen Research Institute, Addis Ababa, 1005, Ethiopia.
Background: According to the Council of International Organizations and Medical Sciences (CIOMS) 2016, post-trial access (PTA) refers to the ethical imperative that requires the sponsor, researchers, and relevant public health authority, "to make available as soon as possible any intervention or product developed, and knowledge generated, for the population or community in which the research is carried out." Law, policy, and practical guidance for PTA has so far been vague but has recently attracted and increased attention in the context of benefit sharing of scientific research results with low- and middle-income countries (LMICs).Although the number of clinical trials conducted in the Sub Saharan (SSA) countries has increased in the past two decades, plans and practices for PTA are underreported.
View Article and Find Full Text PDF